Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
19 11 2019
Historique:
received: 28 02 2018
revised: 18 02 2019
accepted: 25 09 2019
pubmed: 28 10 2019
medline: 23 1 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

Mast cells (MCs) are versatile immune cells capable of rapidly responding to a diverse range of extracellular cues. Here, we mapped the genomic and transcriptomic changes in human MCs upon diverse stimuli. Our analyses revealed broad H3K4me3 domains and enhancers associated with activation. Notably, the rise of intracellular calcium concentration upon immunoglobulin E (IgE)-mediated crosslinking of the high-affinity IgE receptor (FcεRI) resulted in genome-wide reorganization of the chromatin landscape and was associated with a specific chromatin signature, which we term Ca

Identifiants

pubmed: 31653482
pii: S1074-7613(19)30417-0
doi: 10.1016/j.immuni.2019.09.021
pii:
doi:

Substances chimiques

Biomarkers 0
Chromatin 0
FGL2 protein, human 0
Histones 0
Immunoglobulin E 37341-29-0
Fibrinogen 9001-32-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

949-965.e6

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Gökhan Cildir (G)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia; Laboratory of NF-κB Signaling, Institute of Molecular and Cell Biology (IMCB), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.

John Toubia (J)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia; ACRF Cancer Genomics Facility, Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.

Kwok Ho Yip (KH)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.

Mingyan Zhou (M)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.

Harshita Pant (H)

School of Medicine, University of Adelaide, Adelaide, SA, Australia.

Pravin Hissaria (P)

Royal Adelaide Hospital, Adelaide, SA 5000, Australia.

Jingxian Zhang (J)

Institute of Molecular and Cell Biology (IMCB), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.

Wanjin Hong (W)

Institute of Molecular and Cell Biology (IMCB), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.

Nirmal Robinson (N)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.

Michele A Grimbaldeston (MA)

OMNI-Biomarker Development, Genentech Inc, South San Francisco, CA 94080, USA.

Angel F Lopez (AF)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.

Vinay Tergaonkar (V)

Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia; Laboratory of NF-κB Signaling, Institute of Molecular and Cell Biology (IMCB), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore. Electronic address: vinayt@imcb.a-star.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH